Ösophageale Refluxdiagnostik – pH-Metrie, Impedanzmessung, Bilirubin-Messung: Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität und der Arbeitsgruppe Neurogastroenterologie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten

C. Pehl; J. Keller; H.-D. Allescher; H. Feussner; T. Frieling; M. Goebel-Stengel; J. Gschossmann; R. Kuhlbusch-Zicklam; H. Mönnikes; H. N. Nguyen; M. Müller; J. Schirra; M. Storr; I. van der Voort; B. Yüce

doi:10.1055/s-0032-1325483

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2012; 50(12): 1310-1332
DOI: 10.1055/s-0032-1325483

Übersicht

Ösophageale Refluxdiagnostik – pH-Metrie, Impedanzmessung, Bilirubin-Messung: Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität und der Arbeitsgruppe Neurogastroenterologie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten

Diagnosis of Oesophageal Reflux by PH, Impedance, and Bilirubin Measurement: Recommendations of the German Society of Neurogastroenterology and of the Working Group for Neurogastroenterology of the German Society for Digestive and Metabolic Diseases

C. Pehl

¹Medizinische Klinik, Kreiskrankenhaus Vilsbiburg

,

J. Keller

²Medizinische Klinik, Israelitisches Krankenhaus

,

H.-D. Allescher

³Zentrum für Innere Medizin, Klinikum Garmisch-Partenkirchen

,

H. Feussner

⁴Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar

,

T. Frieling

⁵Medizinische Klinik II, HELIOS Klinikum Krefeld

,

M. Goebel-Stengel

⁶Klinik für Innere Medizin, Martin-Luther-Krankenhaus

,

J. Gschossmann

⁷Abt. für Innere Medizin, Klinikum Forchheim

,

R. Kuhlbusch-Zicklam

⁵Medizinische Klinik II, HELIOS Klinikum Krefeld

,

H. Mönnikes

⁶Klinik für Innere Medizin, Martin-Luther-Krankenhaus

,

H. N. Nguyen

⁸Medizinische Klinik, Städtische Kliniken Mönchengladbach GmbH, Elisabeth-Krankenhaus Rheydt

,

M. Müller

⁹Fachbereich Gastroenterologie, Deutsche Klinik für Diagnostik Wiesbaden

,

J. Schirra

¹⁰Medizinische Klinik und Poliklinik II, Klinikum Großhadern

,

M. Storr

¹⁰Medizinische Klinik und Poliklinik II, Klinikum Großhadern

,

I. van der Voort

⁶Klinik für Innere Medizin, Martin-Luther-Krankenhaus

,

B. Yüce

¹⁰Medizinische Klinik und Poliklinik II, Klinikum Großhadern

› Author Affiliations

Abstract

Zusammenfassung

Die vorliegenden Empfehlungen für Indikationen, Durchführung und Interpretation der ösophagealen Refluxdiagnostik stellen eine Aktualisierung der Empfehlungen zur 24 h-pH-Metrie beim Erwachsenen von 2003 dar unter Berücksichtigung der aktuellen Publikationen sowie der neuen Techniken (kabellose) pH-Messung, Impedanz-Messung und Bilirubin-Messung (Bestimmung eines duodenogastroösophagealen Refluxes).

Abstract

The current recommendations on indications, technical performance, and interpretation of diagnostic techniques for oesophageal reflux update the German recommandations about 24 hour pH measurement of 2003. The recommendations encompass conventional pH measurement, wireless pH measurement, pH and impedance measurements, and bilirubin measurement (duodenogastro-oesophageal reflux).

Schlüsselwörter

NERD - GERD - Ösophagus - pH-Metrie - Impedanz-Messung - Bilirubin-Messung

Key words

NERD - GERD - ossophagus - pH metry - impedance measurement - bilirubin measurement

Full Text

References

Literatur
1 Tack J, Talley N, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479
2 Xiao Y, Peng S, Tao J et al. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. Am J Gastroenterol 2010; 105: 2626-2631 . Epub 2010 Sep 7
3 Kaji M, Fujiwara Y, Shiba M et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol 2010; 25: 1151-1156
4 Reimer C, Søndergaard B, Hilsted L et al. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009; 137: 80-87, 87.e1 . Epub 2009 Apr 10
5 Lacy B, Weiser K, Chertoff J et al. The diagnosis of gastroesophageal reflux disease. Am J Med 2010; 123: 583-592 . Epub 2010 May 20
6 Kahrilas P, Quigley E. American Gastroenterological Association medical position statement: guidelines on the use of esophageal pH recording. Gastroenterology 1996; 110: 1981-1996
7 Savarino E, Marabotto E, Zentilin P et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis 2011; 43: 542-547 . Epub 2011 Mar 3
8 Pandolﬁno J, Richter J, Ours T et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-749
9 Tseng D, Rizvi A, Fennerty M et al. Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg 2005; 9: 1043-1051
10 Davies H. Anginal pain of esophageal origin: clinical presentation, prevalence and prognosis. Am J Med 1992; 92 (Suppl. 05) 5S-10S
11 DeMeester T, O’Sullivan G, Bermudez G et al. Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg 1982; 196: 488-498
12 Fennerty M. Extraesophageal gastroesophageal reflux disease. Gastroenterol Clin North Am 1999; 28: 861-873
13 Katz P, Castell D. Approach to the patient with unexplained chest pain. Am J Gastroenterol 2000; 95 (Suppl. 08) S4-S8
14 Lam H, Dekker W, Kann G et al. Acute noncardiac chest pain in a coronary care unit. Evaluation by 24-hour pressure and pH recording of the esophagus. Gastroenterology 1992; 102: 453-460
15 Lux G, Orth K, Boskurt T. Nicht-kardialer Thoraxschmerz – eine Erkrankung der Speiseröhre?. Dtsch Med Wschr 1995; 120: 1748-1755
16 Richter J. Overview of diagnostic testing for chest pain of unknown origin. Am J Med 1992; 92 (Suppl. 05) 41-45S
17 Singh S, Richter J, Hewson E et al. The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann Intern Med 1992; 117: 824-830
18 Smout A, Lam H, Breumelhof R. Ambulatory esophageal monitoring in noncardiac chest pain. Am J Med 1992; 92 (Suppl. 05) 74-83S
19 Stein H, DeMeester T. Therapy of noncardiac chest pain: is there a role for surgery?. Am J Med 1992; 92 (Suppl. 05) 122-128S
20 Ward B, Wu W, Richter J et al. Long-term follow-up of symptomatic status of patients with noncardiac chest pain: is diagnosis of esophageal etiology helpful?. Am J Gastroenterol 1987; 82: 215-218
21 Kim B, Choi S, Kim J et al. Pathological bolus exposure plays a significant role in eliciting non-cardiac chest pain. J Gastroenterol Hepatol 2010; 25: 1855-1860
22 Breumelhof R, Nadorp J, Akkermans L et al. Analysis of 24-hour esophageal pressure and pH data in unselected patients with noncardiac chest pain. Gastroenterology 1990; 99: 1257-1264
23 Garcia-Pulido J, Patel P, Hunter W et al. Esophageal contribution to chest pain in patients with coronary artery disease. Chest 1990; 98: 806-810
24 Midell A, Evander A, DeMeester T et al. A study of the interrelationship between esophageal disease and coronary artery disease as the cause of chest pain. In: Siewert JR, Hölscher AH, (eds) Diseases of the esophagus. New York: Springer-Verlag; 1987. 1. 1092-1102
25 Davies H, Page Z, Rush E et al. Oesophageal stimulation lowers exertional angina threshold. Lancet 1985; 1: 1011-1014
26 Achem S, Kolts B. Current medical therapy for esophageal motility disorders. Am J Med 1992; 92 (Suppl. 05) 98-105S
27 Achem S, Kolts B, MacMath T et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997; 42: 2138-2145
28 Armstrong D, Emde C, Inauen W et al. Diagnostic assessment of gastroesophageal reflux disease: what is possible vs what is practical. Hepatogastroenterology 1992; 39 (Suppl. 01) 3-13
29 Katzka D, Castell D. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol 1994; 89: 989-991
30 Ouatu-Lascar R, Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol 1998; 93: 711-716
31 Gerson L, Boparai V, Ullah N et al. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett’s oesophagus treated with proton pump inhibitors. Aliment Pharmacol Ther 2004; 20: 637-643
32 Fass R, Sampliner R, Malagon I et al. Failure of oesophageal acid control in candidates for Barrett’s oesophagus reversal on a very high dose of proton pump inhibitor. Aliment Pharmacol Ther 2000; 14: 597-602
33 Ouatu-Lascar R, Fitzgerald R, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology 1999; 117: 327-335
34 Clemons N, McColl K, Fitzgerald R. Nitric oxide and acid induce double-strand DNA breaks in Barrett’s esophagus carcinogenesis via distinct mechanisms. Gastroenterology 2007; 133: 1198-1209
35 Souza R. Molecular mechanisms of acid exposure in Barrett’s esophagus. Inflammopharmacology 2007; 15: 95-100
36 de Bortoli N, Martinucci I, Piaggi P et al. Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year. Aliment Pharmacol Ther 2011; 33: 1019-1027
37 Srinivasan R, Katz P, Ramakrishnan A et al. Maximal acid reflux control for Barrett’s oesophagus: feasible and effective. Aliment Pharmacol Ther 2001; 15: 519-524
38 El-Serag H, Aguirre T, Davis S et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett’s esophagus. Am J Gastroenterol 2004; 99: 1877-1883
39 Sharma P, Sampliner R, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett’s esophagus. Am J Gastroenterol 1997; 92: 582-585
40 Wang K, Sampliner R. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 2008; 103: 788-797
41 Spechler S, Sharma P, Souza R et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011; 140: 1084-1091
42 Cooper B, Chapman W, Neumann C et al. Continuous treatment of Barrett’s oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther 2006; 15; 23: 727-733
43 Slaughter J, Goutte M, Rymer J et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011; 9: 868-874
44 Raman A, Sternbach J, Babajide A et al. When does testing for GERD become cost effective in an integrated health network?. Surg Endosc 2010; 24: 1245-1249
45 Ang D, Ang T, Teo E et al. Is impedance pH monitoring superior to the conventional 24-h pH meter in the evaluation of patients with laryngorespiratory symptoms suspected to be due to gastroesophageal reflux disease?. J Dig Dis 2011; 12: 341-348
46 Del Genio G, Tolone S, Del Genio F et al. Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring. J Gastrointest Surg 2008; 12: 1491-1496
47 Karamanolis G, Kotsalidis G, Triantafyllou K et al. Yield of Combined Impedance-pH Monitoring for Refractory Reflux Symptoms in Clinical Practice. J Neurogastroenterol Motil 2011; 17: 158-163
48 Mainie I, Tutuian R, Agrawal A et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006; 93: 1483-1487
49 Conchillo J, Schwartz M, Selimah M et al. Role of intra-oesophageal impedance monitoring in the evaluation of endoscopic gastroplication for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007; 26: 61-68
50 Yigit T, Quiroga E, Oelschlager B et al. Multichannel intraluminal impedance for the assessment of post fundoplication dysphagia. Dis Esophagus 2006; 19: 382-388
51 Arnold B, Dunst C, Gill A et al. Postoperative Impedance-pH Testing is Unreliable After Nissen Fundoplication With or Without Giant Hiatal Hernia Repair. J Gastrointest Surg 2011; 15: 1506-1512
52 Pehl C, Wendl B, Greiner I et al. Abnormal oesophageal pH-monitoring in patients with functional thoracic and abdominal disorders. Gastroenterol Clin Biol 1995; 19: 367-372
53 Pfeiffer A, Aronbayev J, Schmidt T et al. Gastric emptying, esophageal 24-hour pH and gastric potential difference measurements in non-ulcer dyspepsia. Gastroenterol Clin Biol 1992; 16: 395-400
54 Savarino E, Pohl D, Zentilin P et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut 2009; 58: 1185-1191
55 Cherry J, Margulies S. Contact uler of the larynx. Laryngoscope 1968; 78: 1937-1940
56 Labenz J. Facts and fantasies in extra-oesophageal symptoms in GORD. Best Pract Res Clin Gastroenterol 2010; 24: 893-904
57 Vakil N, van Zanten S, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-1920
58 Lazarchik D, Filler S. Dental erosion: predominant oral lesion in gastroesophageal reflux disease. Am J Gastroenterol 2000; 95: S33-S38
59 Lazarchik D, Filler S. Effects of gastroesophageal reflux on the oral cavity. Am J Med 1997; 103 (Suppl. 05) 107-113
60 Schroeder P, Filler S, Ramirez B et al. Dental erosion and acid reflux disease. Ann Intern Med 1995; 122: 809-815
61 Sudhoff H, Euteneuer S, Dazert S et al. Gastroösophagealer Reflux-Ursache von Otitis media mit Erguss im Kindesalter?. HNO 2004; 52: 8-10
62 Tasker A, Dettmar P, Panetti M et al. Is gastric reflux a cause of otitis media with effusion in children?. Laryngoscope 2002; 112: 1930-1935
63 Flook E, Kumar B. Is there evidence to link acid reflux with chronic sinusitis or any nasal symptoms? A review of the evidence. Rhinology 2011; 49: 11-16
64 Vaezi M, Hagaman D, Slaughter J. Proton pump inhibitor therapy improves symptoms in postnasal drainage. Gastroenterology 2010; 139: 1887-1893 . Epub 2010 Aug 27
65 Tae K, Jin B, Ji Y et al. The role of laryngopharyngeal reflux as a risk factor in laryngeal cancer: a preliminary report. Clin Exp Otorhinolaryngol 2011; 4: 101-104 . Epub 2011 May 31
66 Ford C. GERD-related chronic laryngitis: pro. Arch Otolaryngol Head Neck Surg 2010; 136: 910-913
67 Gatta L, Vaira D, Sorrenti G et al. Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007; 25: 385-392
68 Quadeer M, Phillips C, Lopez A et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006; 101: 2646-2654 . Epub 2006 Oct 13
69 Hopkins C, Yousaf U, Pedersen M. Acid reflux treatment for hoarseness. Cochrane Database Syst Rev 2006; 1: CD005054
70 Vaezi M. Gastroesophageal reflux-related chronic laryngitis: con. Arch Otolaryngol Head Neck Surg 2010; 136: 908-909
71 Vaezi M. Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006; 23 (Suppl. 01) 40-49
72 Jacob P, Kahrilas P, Herzon G. Proximal esophageal pH-metry in patients with ‘reflux laryngitis’. Gastroenterology 1991; 100: 305-310
73 Mc Collough M, Jabbar A, Caccione R et al. Proximal sensor data from routine dual-sensor esophageal pH monitoring is often inaccurate. Dig Dis Sci 2004; 49: 1607-1611
74 Postma G. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol 2000; 184: 10-14
75 Dobhan R, Castell D. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe monitoring. Am J Gastroenterol 1993; 88: 25-29
76 Ceccati P, Mariottini M, Agnolucci A et al. Acid exposure of proximal esophagus in healthy subjects. Minverva Gastroenterol Dietol 1998; 44: 129-134
77 Ayazi S, Hagen J, Zehetner J et al. Proximal esophageal pH monitoring: improved definition of normal values and determination of a composite pH Score. J Am Coll Surg 2010; 210: 345-350
78 Oelschlager B, Quiroga E, Isch J et al. Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment. J Gastrointest Surg 2006; 10: 54-62
79 Kawamura O, Aslam M, Rittmann T et al. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol 2004; 99: 1000-1010
80 Patterson N, Mainie I, Rafferty G et al. Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol 2009; 43: 414-419
81 Samuels T, Johnston N. Pepsin as a causal agent of inflammation during nonacidic reflux. Otolaryngol Head Neck Surg 2009; 141: 559-563
82 Mazzini Gda S, Gurski R. Impact of laparoscopic fundoplication for the treatment of laryngopharyngeal reflux: review of the literature. Int J Otolaryngol 2012; 2012: 291472 . Epub 2011 Dec 15
83 Chiou E, Rosen R, Jiang H et al. Diagnosis of supra-esophageal gastric reflux: correlation of oropharyngeal pH with esophageal impedance monitoring for gastro-esophageal reflux. Neurogastroenterol Motil 2011; 23: 717-e326 . Epub 2011 May 18
84 Wang A, Liang M, Jiang A et al. Predictors of acid suppression success in patients with chronic laryngitis. Neurogastroenterol Motil 2012; 25 . [Epub ahead of print]
85 Sun G, Muddana S, Slaughter J et al. A new pH catheter for laryngopharyngeal reflux: Normal values. Laryngoscope 2009; 119: 1639-1643
86 Chheda N, Seybt M, Schade R et al. Normal values for pharyngeal pH monitoring. Ann Oncol Rhinol Laryngol 2009; 118: 166-171
87 Wiener G, Tsukashima R, Wolf E et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice 2009; 23: 498-504
88 Golub J, Johns M, Lim J et al. Comparison of an oropharyngeal pH probe and a standard dual pH probe for diagnosis of laryngoesophageal reflux. Ann Oncol Rhinol Laryngol 2009; 118: 1-5
89 Ayazi S, Lipham J, Hagen J et al. A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg 2009; 13: 1422-1429 . Epub 2009 May 7
90 Vincent D, Garrett J, Radionoff S et al. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice 2000; 14: 247-254
91 Ing A. Cough and gastroesophageal reflux. Am J Med 1997; 103 05a 915-965
92 Irwin R, Madison J, Fraire A. The Cough reflex and its relation to gastroesophageal reflux. Am J Med 2000; 108 (Suppl. 04) 73S-78S
93 Irwin R, Richter J. Gastroesophageal reflux and chronic cough. Am J Gastroenterol 2000; 95 (Suppl. 08) S9-S14
94 Irwin R, Zawacki J. Accurately diagnoxing and successfully treating chronic cough due to gastroesophageal reflux disease can be difficult. Am J Gastroenterol 1999; 94: 3095-3098
95 Ours T, Kavuru M, Schilz R et al. A prospective evaluation of esophageal testing and a double-blind, randomizes study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131-3138
96 Jaspersen D, Kulig M, Labenz J. Prevalence of extra-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003; 17: 1515-1520
97 Kollarik M, Ru F, Undem B. Acid-sensitive vagal sensory pathways and cough. Pulm Pharmacol Ther 2007; 20: 402-411 Epub 2006 Dec13
98 Tobey N, Carson J, Alkiek R et al. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996; 111: 1200e5
99 Farré R, De Vos R, Geboes K et al. Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut 2007; 56: 1191e7
100 Harding S, Richter J. The role of gastroesophageal reflux in chronic cough and asthma. Chest 1997; 111: 1389-1402
101 Ing A, Ngu M, Breslin A. Chronic persistent cough and gastro-oesophageal reflux. Thorax 1991; 46: 479-483
102 Shaheen N, Crockett S, Bright S et al. Randomised clinical trial: high-dose acid suppression for chronic cough – a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 225-234 . Epub 2010 Nov 17
103 Kiljander T, Salomaa E, Hietanen E et al. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000; 16: 633-638
104 Chang A, Lasserson T, Gaffney J et al. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 2011; 1: CD004823
105 Irwin R, Zawacki J, Wilson M et al. Chronic cough due to gastroesophageal reflux disease: failure to resolve despite total/near-total elimination of esophageal acid. Chest 2002; 121: 1132-1144
106 Benini L, Ferrari M, Sembenini C et al. Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage. Gut 2000; 46: 762-767
107 Bajbouj M, Becker V, Neuber M et al. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion 2007; 76: 223-228 . Epub 2007 Dec 21
108 Sifrim D, Dupont L, Blondeau K et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 2005; 54: 449-454
109 Blondeau K, Dupont L, Mertens V et al. Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough. Aliment Pharmacol Ther 2007; 25: 723-732
110 Tutuian R, Mainie I, Agrawal A et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006; 130: 386-391
111 Rakita S, Villadolid D, Thomas A et al. Laparoscopic Nissen fundoplication offers high patient satisfaction with relief of extraesophageal symptoms of gastroesophageal reflux disease. Am Surg 2006; 72: 207-212
112 Van der Westhuizen L, Von S, Wilkerson B et al. Impact of Nissen fundoplication on laryngopharyngeal reflux symptoms. Am Surg 2011; 77: 878-882
113 Brown S, Gyawali C, Melman L et al. Clinical outcomes of atypical extra-esophageal reflux symptoms following laparoscopic antireflux surgery. Surg Endosc 2011; 25: 3852-3858
114 Iqbal M, Batch A, Spychal R et al. Outcome of surgical fundoplication for extraesophageal (atypical) manifestations of gastroesophageal reflux disease in adults: a systematic review. J Laparoendosc Adv Surg Tech A 2008; 18: 789-796
115 Paterson W, Murat B. Combined ambulatory esophageal manometry and dual-probe pH-metry in evaluation of patients with chronic unexplained cough. Dig Dis Sci 1994; 39: 1117-1125
116 Bogte A, Bredenoord A, Smout A. Diagnostic yield of oesophageal pH monitoring in patients with chronic unexplained cough. Scand J Gastroenterol 2008; 43: 13-19
117 Smith J, Decalmer S, Kelsall A et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 2010; 139: 754-762 . Epub 2010 Jun 20
118 Chang A, Connor F, Petsky H et al. An objective study of acid reflux and cough in children using an ambulatory pHmetry-cough logger. Arch Dis Child 2011; 96: 468-472 . Epub 2010 Jun 1
119 Blondeau K, Mertens V, Dupont L et al. The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH-manometry recordings. Pediatr Pulmonol 2010; [Epub ahead of print]
120 Tuchman D, Boyle J, Pack A et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984; 87: 872-881
121 Allen G, Leclair T, von Reyn J et al. Acid aspiration-induced airways hyperresponsiveness in mice. J Appl Physiol 2009; 107: 1763-1770
122 Jack C, Calverley P, Donnelly R et al. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995; 50: 201-204
123 Gold B. Asthma and gastroesophageal reflux disease in children: exploring the relationship. J Pediatr 2005; 146: S13-S20
124 Harding S, Guzzo M, Richter J. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 2000; 162: 34-39
125 Kiljander T, Laitinen J. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 2004; 126: 1490-1494
126 Leggett J, Johnston B, Mills M et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest 2005; 127: 1227-1231
127 Littner M, Leung F, Ballard E et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005; 128: 1128-1135
128 Kiljander T, Harding S, Field S et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2006; 173: 1091-1097
129 Mastronarde J, Anthonisen N, Castro M et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360: 1487-1499
130 Chan W, Chiou E, Obstein K et al. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. Arch Intern Med 2011; 171: 620-629
131 Tutuian R, Mainie I, Agrawal A et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 2006; 130: 386-391
132 Pacheco-Galván A, Hart S, Morice A. Relationship between gastro-oesophageal reflux and airway diseases: the airway reflux paradigm. Arch Bronconeumol 2011; 47: 195-203 . Epub 2011 Apr 2
133 Hershcovici T, Jha L, Johnson T et al. Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011; 34: 1295-1305 . Epub 2011 Oct 17
134 Moraes-Filho J, Navarro-Rodriguez T, Barbuti R et al. Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus. Arq Gastroenterol 2010; 47: 99-115
135 Pauwels A, Decraene A, Blondeau K et al. Bile acids in sputun and increased airway inflammation in patients with cystic fibrosis. Chest 2012; 141: 1568-1574 . Epub 2011 Dec 1
136 Blondeau K, Dupont L, Mertens V et al. Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 2008; 57: 1049-1055 . Epub 2008 Mar 27
137 Fass R. Proton pump inhibitor failure – what are the therapeutic options?. Am J Gastroenterol 2009; 104 (Suppl. 02) S33-S38
138 Inadomi J, McIntyre L, Bernard L et al. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs. Am J Gastroenterol 2003; 98: 1940-1944
139 Carlsson R, Dent J, Watts R et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998; 10: 119-124
140 Martinez S, Malagon I, Garewal H et al. Non-erosive reflux disease (NERD) – acid reflux and symptom patterns. Aliment Pharmacol Ther 2003; 17: 537-545
141 Bardhan K. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995; 9 (Suppl. 01) 15-25
142 Fass R, Fennerty M, Vakil N. Nonerosive reflux disease – current concepts and dilemmas. Am J Gastroenterol 2001; 96: 303-314
143 Fass R, Sampliner R. Barrett’s oesophagus: optimal strategies for prevention and treatment. Drugs 2003; 63: 555-564
144 Fass R. Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs 2007; 67: 1521-1530
145 Dean B, Gano Jr A, Knight K et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 656-664
146 Richter J. How to manage refractory GERD. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 658-664
147 Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58: 295-309
148 Vela M, Camacho-Lobato L, Srinivasan R et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001; 120: 1599-1606
149 Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-1402
150 Zerbib F, Roman S, Ropert A et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006; 101: 1956-1963
151 Tack J, Koek G, Demedts I et al. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett’s esophagus: acid reflux, bile reflux, or both?. Am J Gastroenterol 2004; 99: 981-988
152 Pace F, Sangaletti O, Pallotta S et al. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring. Scand J Gastroenterol 2007; 42: 1031-1039
153 Sifrim D, Holloway R, Silny J et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001; 120: 1588-1598
154 Sifrim D. Acid, weakly acidic and non-acid gastro-oesophageal reflux: differences, prevalence and clinical relevance. Eur J Gastroenterol Hepatol 2004; 16: 823-830
155 Vaezi M, Lacamera R, Richter J. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994; 267: G1050-G1057
156 Champion G, Richter J, Vaezi M et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology 1994; 107: 747-754
157 Netzer P, Gut A, Brundler R et al. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Aliment Pharmacol Ther 2001; 15: 1375-1384
158 Todd J, Basu K, de Caestecker J. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett’s oesophagus. Aliment Pharmacol Ther 2005; 21: 969-975
159 Fass R, Mackel C, Sampliner R. 24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment. J Clin Gastroenterol 1994; 19: 97-99
160 Katzka D, Paoletti V, Leite L et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 1996; 91: 2110-2113
161 Zerbib F, Duriez A, Roman S et al. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 2008; 57: 156-160
162 Emerenziani S, Sifrim D, Habib F et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 2008; 57: 443-447
163 Bredenoord A, Weusten B, Timmer R et al. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol 2005; 100: 265-269
164 Bredenoord A, Weusten B, Curvers W et al. Determinants of perception of heartburn and regurgitation. Gut 2006; 55: 313-318
165 Hemmink G, Bredenoord A, Weusten B et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: ‘on’ or ‘off’ proton pump inhibitor?. Am J Gastroenterol 2008; 103: 2446-2453
166 Anforderung an die Hygiene bei der Aufbereitung flexibler Endoskope und endoskopischen Zusatzinstrumentariums. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2002; 45: 395-411
167 Anforderung an die Hygiene bei der Aufbereitung von Medizinprodukten. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut und des Bundesinstitut für Arzneimittel und Medizinprodukte zu den „Anforderungen an die Hygiene bei der Aufbereitung von Medizinprodukten“. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2001; 44: 1115-1126
168 Emde C, Garner A, Blum AL. Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 1987; 28: 1177-1188
169 Galmiche JP, Scarpignato C. Esophageal pH monitoring. Functional evaluation in esophageal disease. Front Gastrointest Res 1994; 22: 71-108
170 Mattox H, Richter J. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med 1990; 89: 345-356
171 McLauchlan G, Buchanan N, Crean G et al. An endoscopic procedure for accurate localisation of intraluminal pH electrodes. Endoscopy 1987; 19: 124-126
172 Vandenplas Y, Helven R, Goyvaerts H. Comparative study of glass and antimony electrodes for continuous oesophageal pH monitoring. Gut 1991; 32: 708-712
173 Ask P, Edwall G, Johansson K. Accuracy and choice of procedures in 24-hour oesophageal pH monitoring with monocrystalline antimony electrodes. Med Biol Eng Comput 1986; 24: 602-608
174 Richter J, Bradley L, DeMeester T et al. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-856
175 Anggiansah A, Sumboonnanonda K, Wang J et al. Significantly reduced acid detection at 10 centimeters compared to 5 centimeters above the lower esophageal sphincter in patients with acid reflux. Am J Gastroenterol 1993; 88: 842-846
176 Johansson KE, Tibbling L. Evaluation of the 24-hour pH test at two different levels of the esophagus. In: DeMeester TR, Skinner DB, (eds) Esophageal disorders: pathophysiology and therapy. New York.: Raven Press; 1985: 579-582
177 Lehman G, Rogers D, Cravens E et al. Prolonged pH probe testing less than 5 cm above the lower esophageal sphincter (LES): Establishing normal control values. Gastroenterology 1990; 98: A77
178 Ruiz de Leon A, Sevilla-Mantilla C, Perez de la Serna J et al. Simultaneous two-level esophageal 24-hour pH monitoring in patients with mild and severe esophagitis. Does probe position influence results of esophageal monitoring?. Dig Dis Sci 1995; 40: 1423-1427
179 Shaker R, Dodds W, Helm J et al. Regional esophageal distribution and clearance of refluxed gastric acid. Gastroenterology 1991; 101: 355-359
180 Singh P, Taylor R, Colin-Jones D. Simultaneous two level oesophageal pH monitoring in healthy controls and patients with oesophagitis: comparison between two positions. Gut 1994; 35: 304-308
181 DeMeester T, Johnson L, Joseph G et al. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976; 184: 459-470
182 Johnson L, DeMeester T. Twenty-four hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974; 62: 325-332
183 DeVault K, Castell D. A simplified technique for accurate placement of ambulatory pH probes. Am J Gastroenterol 1991; 86: 380-381
184 Kahrilas P, Quigley E. American Gastroenterological Association medical position statement: Guidelines on the use of esophageal pH recording. Gastroenterology 1996; 110: 1981-1996
185 Singh S, Price J, Richter J. The LES locator: accurate placement of an electrode for 24-hour pH measurement with a combined solid state pressure transducer. Am J Gastroenterol 1992; 87: 967-970
186 Klauser A, Schindlbeck N, Müller-Lissner S. Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode?. Am J Gastroenterol 1990; 85: 1463-1467
187 Klingler P, Hinder R, Wetscher G et al. Accurate placement of the esophageal pH electrode for 24-hour pH monitoring using a combined pH/manometry probe. Am J Gastroenterol 2000; 95: 906-909
188 Marples M, Mughal M, Bancewicz J. Can an esophageal pH electrode be accurately positioned without manometry?. In: Siewert JR, Hoelscher AH, (eds) Diseases of the esophagus. Berlin Heidelberg New York: Springer; 1987: 789-791
189 Mattox H, Richter J, Sinclair J et al. Gastroesophageal pH step-up inaccurately locates proximal border of lower esophageal sphincter. Dig Dis Sci 1992; 37: 1185-1191
190 Pehl C, Boccali I, Wendl B et al. Results of dual probe pH-metry with probe positioning either by manometry or pH step-up in healthy volunteers and patients with gastroesophageal reflux disease. Gut 1999; 45: A46
191 Rokkas T, Anggiansah A, Dorrington L et al. Accurate positioning of the pH-probe in the oesophagus without manometry. Ital J Gastroenterol 1987; 19: 176-178
192 Walther B, DeMeester T. Placement of the esophageal pH electrode for 24-hour esophageal pH monitoring. In: DeMeester TR, Skinner DB, (eds) Esophageal disorders: Pathophysiology and therapy. New York: Raven Press; 1985: 539-541
193 Pehl C, Boccali I, Hennig M et al. pH probe positioning for 24 hour pH-metry by manometry or pH step-up. Eur J Gastroenterol Hepatol 2004; 16: 375-382
194 Fatih Can M, Yagci G, Cetiner S et al. Accurate positioning of the 24-hour pH monitoring catheter: Agreement between manometry and pH step-up method in two patient positions. World J Gastroenterol 2007; 13: 6197-6202
195 Fletcher J, Wirz A, Henry E et al. Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux. Gut 2004; 53: 168-167
196 Vincent Jr D, Garrett J, Radionoff S et al. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice 2000; 14: 247-254
197 Williams R, Ali G, Wallace K et al. Esophagopharyngeal acid regurgitation: dual pH monitoring criteria for its detection and insights into mechanisms. Gastroenterology 1999; 117: 1051-1061
198 Ulualp S, Toohill R, Shaker R. Pharyngeal acid reflux in patients with single and multiple otolaryngologic disorders. Otolaryngol Head Neck Surg 1999; 121: 725-730
199 Wong R, Hanson D, Waring P et al. ENT manifestations of gastroesophageal reflux. Am J Gastroenterol 2000; 95 (Suppl. 08) S15-S22
200 Ergun G, Kahrilas P. Clinical applications of esophageal manometry and pH monitoring. Am J Gastroenterol 1996; 91: 1077-1089
201 Hendrix T. pH monitoring: is it the gold standard for the detection of gastroesophageal reflux disease?. Dysphagia 1993; 8: 122-124
202 Clark C, Kraus B, Sinclair J et al. Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA 1989; 261: 3599-3601
203 Shawdon A. Gastro-oesophageal reflux and exercise. Important pathology to consider in the athletic population. Sports Med 1995; 20: 109-116
204 Richter J. Ambulatory esophageal pH monitoring. Am J Med 1997; 103: 130S-134S
205 Savarino V, Mela G, Zentilin P et al. Esophageal pH monitoring: factors influencing the definition of normality. Minerva Chir 1991; 46: 103-109
206 Wo J, Castell D. Exclusion of meal periods from ambulatory 24-hour pH monitoring may improve diagnosis of esophageal acid reflux. Dig Dis Sci 1994; 39: 1601-1607
207 Shay S, Conwell D, Mehindru V et al. The effect of posture on gastroesophageal reflux event frequency and composition during fasting. Am J Gastroenterol 1996; 91: 54-60
208 Jamieson J, Stein H, DeMeester T et al. Ambulatory 24-h esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 1102-1111
209 Bianchi Porro G, Pace F. Comparison of three methods of intraesophageal pH recordings in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol 1988; 23: 743-750
210 Dhiman R, Saraswat V, Mishra A et al. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 1996; 41: 764-772
211 Dobhan R, Castell D. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with “24-hr” analysis. Dig Dis Sci 1992; 37: 857-864
212 Fink S, McCallum R. The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA 1984; 252: 1160-1164
213 Grande L, Pujol A, Ros E et al. Intraesophageal pH monitoring after breakfast + lunch in gastroesophageal reflux. J Clin Gastroenterol 1988; 10: 373-376
214 Jorgensen F, Elsborg L, Hesse B. The diagnostic value of computerized short-term oesophageal pH-monitoring in suspected gastro-oesophageal reflux. Scand J Gastroenterol 1988; 23: 363-368
215 Dobhan R, Castell D. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with “24-hr” analysis. Dig Dis Sci 1992; 37: 857-864
216 Schindlbeck N, Ippisch H, Klauser A et al. Which pH threshold is best in esophageal pH monitoring. Am J Gastroenterol 1991; 86: 1138-1141
217 Tytgat G, Bennett J, Dent J et al. Oesophageal pH monitoring – normal and abnormal. Gastroenterol Int 1989; 2: 141-149
218 Dinelli M, Passaretti S, Di Francia I et al. Area under pH 4: a more sensitive parameter for the quantitative analysis of esophageal acid exposure in adults. Am J Gastroenterol 1999; 94: 3139-3144
219 Ter R, Johnston B, Castell D. Exclusion of meal period improves the clinical reliability of esophageal pH monitoring. J Clin Gastroenterol 1997; 25: 314-316
220 Tovar J, Izquierdo M, Eizaguirre I. The area under pH curve: a single-figure parameter representative of esophageal acid exposure. J Pediatr Surg 1991; 26: 163-167
221 Vandenplas Y, Franckx-Gossens A, Pipeleers-Marichal M et al. Area under pH 4: advantages of a new parameter in the interpretation of esophageal pH monitoring data in infants. J Pediatr Gastroenterol Nutr 1989; 9: 34-39
222 Johnson L, DeMeester T. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol 1986; 8 (Suppl. 01) 52-58
223 Schindlbeck N, Heinrich C, König A et al. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987; 93: 85-90
224 Vandenplas Y, Helven R, Goyvaerts H et al. Reproducibility of continuous 24 hour oesophageal pH monitoring in infants and children. Gut 1990; 31: 374-377
225 Ward B, Wu W, Richter J et al. Ambulatory 24-hour esophageal pH monitoring. Technology searching for a clinical application. J Clin Gastroenterol 1986; 8 (Suppl. 01) 59-67
226 Wiener G, Morgan T, Copper J et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988; 33: 1127-1133
227 Parilla P, Martinez de Haro L, Ortiz A et al. Can pH recordings suggest defective esophageal peristalsis in patients with gastroesophageal reflux. Scand J Gastroenterol 1992; 27: 929-932
228 Stanciu C, Bennett J. Oesophageal acid clearing: one factor in the production of reflux oesophagitis. Gut 1974; 15: 852-857
229 Orenstein S, Izadnia F, Khan S. Gastroesophageal reflux disease in children. Gastroenterol Clin North Am 1999; 28: 947-969
230 Vandenplas Y, Goyvaerts H, Helven R et al. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics 1991; 88: 834-840
231 Boesby S. Continuous oesophageal pH recording and acid-clearing test. A study of reproducibility. Scand J Gastroenterol 1977; 12: 245-247
232 Bontempo I, Corazziari E, Tosoni M et al. Reproducibility of esophageal pH-metric measurements. Gastroenterology 1985; 88: A1331
233 Hampton F, MacFayden U, Simpson H. Reproducibility of 24 hour oesophageal pH studies in infants. Arch Dis Child 1990; 65: 1249-1254
234 Herrera J, Simpson III J, Maydonovitch C et al. Comparison of stationary vs. ambulatory 24-hour pH monitoring recording systems. Dig Dis Sci 1988; 33: 385-388
235 Johnsson F, Joelsson B. Reproducibility of ambulatory oesophageal pH monitoring. Gut 1988; 29: 886-889
236 Ayazi S, Lipham J, Portale G et al. Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol 2009; 7: 60-67 . Epub 2008 Aug 16
237 des Varannes S, Mion F, Ducrotte P et al. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005; 54: 1682-1686
238 Hampton F, MacFayden U, Mayberry J. Variations in results of simultaneous ambulatory esophageal pH monitoring. Dig Dis Sci 1992; 37: 506-512
239 Murphy D, Faust K, Chiantella V et al. Assessment of accuracy of intraesophageal pH probe in a dog model. Dig Dis Sci 1989; 34: 1079-1084
240 Murphy D, Yuan Y, Castell D. Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci 1989; 34: 649-656
241 Patti M, Diener U, Tamburini A et al. Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 2001; 46: 597-602
242 Johnston B, Collins J, McFarland R et al. Are esophageal symptoms reflux-related? A study of different scoring systems in a cohort of patients with heartburn. Am J Gastroenterol 1994; 89: 497-502
243 Watson R, Tham T, Johnston B et al. Double-blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux – the “sensitive oesophagus”. Gut 1997; 40: 587-590
244 Baldi F, Ferrarini F, Longanesi A et al. Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci 1989; 34: 1890-1893
245 Weusten B, Akkermans L, vanBerge-Henegouwen G et al. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology 1995; 108: 1739-1744
246 Smith J, Opekun A, Larkai E et al. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989; 96: 683-689
247 Rodriguez-Stanley S, Robinson M, Earnest D et al. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999; 94: 628-631
248 Shi G, Bruley des Varannes S, Scarpignato C et al. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457-464
249 Fass R, Pulliam G, Johnson C et al. Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Age Aging 2000; 29: 125-130
250 Bradley L, Richter J, Pulliam T et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993; 88: 11-19
251 Johnston B, Lewis S, Love A. Psychological factors in gastro-oesophageal reflux disease. Gut 1995; 36: 481-482
252 Janssens J, Vantrappen G. Irritable esophagus. Am J Med 1992; 92 (Suppl. 05) 27-32S
253 Pandolﬁno J, Richter J, Ours T et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-749
254 Ghillebert G, Janssens J, Vantrappen G et al. Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 1990; 31: 738-744
255 Fass R, Naliboff B, Higa L et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998; 115: 1363-1373
256 Peters L, Maas L, Petty D et al. Spontaneous noncardiac chest pain. Evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Gastroenterology 1988; 94: 878-886
257 Soffer E, Scalabrini P, Wingate D. Spontaneous noncardiac chest pain: value of ambulatory esophageal pH and motility monitoring. Dig Dis Sci 1989; 34: 1651-1655
258 Lam H, Breumelhof R, Roelofs J et al. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data?. Dig Dis Sci 1994; 39: 402-409
259 Singh S, Richter J, Bradley L et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 1993; 38: 1402-1408
260 Wiener G, Richter J, Copper J et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83: 358-361
261 Hewson E, Sinclair J, Dalton C et al. Acid perfusion test: does it have a role in the assessment of noncardiac chest pain?. Gut 1989; 30: 305-310
262 Howard P, Maher L, Pryde A et al. Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut 1991; 32: 128-132
263 Johnsson F, Joelsson B, Gudmundsson K et al. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987; 22: 714-718
264 Breumelhof R, Smout A. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991; 86: 160-164
265 Lloyd D, Borda I. Food-induced heartburn: Effect of osmolality. Gastroenterology 1981; 80: 740-741
266 Price S, Smithson K, Castell D. Food sensitivity in reflux esophagitis. Gastroenterology 1978; 75: 240-243
267 Yeoh K, Ho K, Guan R et al. How does chili cause upper gastrointestinal symptoms? A correlation study with esophageal mucosal sensitivity and esophageal motility. J Clin Gastroenterol 1995; 21: 87-90
268 Weusten B, Roelofs J, Akkermans L et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741-1745
269 Aanen M, Bredenoord A, Numans M et al. Reproducibility of symptom association analysis in ambulatory reflux monitoring. Am J Gastroenterol 2008; 103: 2200-2208
270 Emde C, Armstrong D, Blum A. Chest pain due to gastroesophageal reflux: presentation of a mathematical procedure to assess ist significance. J Gastrointest Motil 1990; 2: 140
271 Richter J, Bradley L, DeMeester T et al. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992; 37: 849-856
272 Sweis R, Fox M, Anggiansah R et al. Patient Acceptance and Clinical Impact of Bravo Monitoring in Patients with Previously Failed Catheter-Based Studies. Aliment Pharmacol Ther 2009; 29: 669-676
273 Wenner J, Johnsson F, Johansson J et al. Wireless Esophageal pH Monitoring is Better Tolerated than the Catheter-Based Technique: Results from a Cross-Over Trial. Am J Gastroenterol 2007; 102: 239-245
274 Hirano I, Zhang Q, Pandolfino J et al. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2005; 3: 1083-1088
275 Ward E, DeVault K, Bouras E et al. Successful oesophageal pH monitoring with a catheter-free system. Aliment Pharmacol Ther 2004; 19: 449-454
276 Bhat Y, McGrath K, Bielefeldt K. Wireless esophageal pH monitoring: new technique means new questions. J Clin Gastroenterol 2006; 40: 116-121
277 Roman S, Mion F, Zerbig F et al. Wireless pH capsule – yield in clinical practice. Endoscopy 2012; 44: 270-276
278 Lacy B, O’Shana T, Hynes M et al. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol 2007; 102: 24-32
279 Marchese M, Spada C, Iacopini F et al. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure. Endoscopy 2006; 38: 813-818
280 Nusrat S, Roy P, Bielefeldt K. Wireless ambulatory pH studies: manometric or endoscopic guidance?. Dis Esophagus 2012; 25: 26-32
281 Doma S, Paladugu S, Parkman H et al. Wireless capsules for esophageal pH monitoring: are we placing them correctly?. Digestion 2010; 82: 54-59
282 Sofi A, Filipiak C, Sodeman T et al. Comparison of esophageal placement of Bravo capsule system under direct endoscopic guidance with conventional placement method. Clin Exp Gastroenterol 2010; 3: 147-151
283 Sofi A, Filipiak C, Sodeman T et al. Comparison of esophageal placement of Bravo capsule system under direct endoscopic guidance with conventional placement method. Turk J Gastroenterol 2011; 22: 243-248
284 Hogan R, Phillips P, Boyd S et al. Two-year retention of Bravo capsule in a giant colonic diverticulum. Am J Gastroenterol 2009; 104: 1062
285 Remes-Troche J, Ibarra-Palomino J, Carmona-Sanchez R et al. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico. Am J Gastroenterol 2005; 100: 2382-2386
286 Valdovinos Diaz M, Remes TrocheJ, Ruiz AguilarJ et al. Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease. Rev Gastroenterol Mex 2004; 69: 62-68
287 Ang D, Teo E, Ang T et al. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort. J Dig Dis 2010; 11: 19-27
288 Ahlawat S, Novak D, Williams D et al. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system. J Clin Gastroenterol 2006; 40: 20-24
289 de Hoyos A, Esparza E. Technical problems produced by the Bravo pH test in nonerosive reflux disease patients. World J Gastroenterol 2010; 16: 3183-3186
290 de Hoyos A, Esparza E, Loredo M. Cold and hot snare endoscopic techniques for removal of the Bravo pH monitoring capsule. Digestion 2009; 79: 14-16
291 Agrawal D, Akerman P, Rich H. Removal of a Bravo 24-hour pH capsule with endoscopic scissors. Gastrointest Endosc 2009; 70: 385-386
292 Fajardo N, Wise J, Locke G et al. Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc 2006; 63: 184-185
293 von Renteln D, Kayser T, Riecken B et al. An unusual case of Bravo capsule aspiration. Endoscopy 2008; 40 (Suppl. 02) E174
294 Korrapati V, Babich J, Balani A et al. Does deep sedation impact the results of 48 hours catheterless pH testing?. World J Gastroenterol 2011; 17: 1304-1307
295 Chander B, Hanley-Williams N, Deng Y et al. 24 Versus 48-hour Bravo pH Monitoring. J Clin Gastroenterol 2011; [Epub ahead of print]
296 Sweis R, Fox M, Anggiansah A et al. Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil 2011; 23: 419-426 . Epub 2011 Jan 16
297 Prakash C, Clouse R. Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol 2006; 101: 446-452
298 Grigolon A, Bravi I, Cantù P et al. Wireless pH monitoring: better tolerability and lower impact on daily habits. Dig Liver Dis 2007; 39: 720-724 . Epub 2007 Jun 29
299 Gillies R, Stratford J, Booth M et al. Oesophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol 2007; 19: 57-63
300 Sweis R, Fox M, Anggiansah A et al. Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil 2011; 23: 419-426 . Epub 2011 Jan 16
301 Mönkemüller K, Neumann H, Fry L et al. Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD). Z Gastroenterol 2009; 47: 351-356 . Epub 2009 Apr 8
302 Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastointest Mot 1991; 3: 151-162
303 Nguyen H, Silny J, Albers D et al. Dynamics of esophageal bolus transport in healthy sujects studied using multiple intraluminal impedancometry. Am J Physiol Gastrointest Liver Physiol 1997; 273: G958-G964
304 Nguyen H, Silny J, Matern S. Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: current results and further implications. Am J Gastroenterol 1999; 94: 306-317
305 Skopnik H, Silny J, Heiber O et al. Gastroesophageal reflux in infants: Evaluation of a new intraluminal technique. J Pediatr Gastroenterol Nutr 1996; 23: 591-598
306 Sifrim D, Silny J, Holloway R et al. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 1999; 44: 47-54
307 Sifrim D, Castell D, Dent J. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-1031
308 Hemmink G, Bredenoord A, Aanen M et al. Computer analysis of 24-h esophageal impedance signals. Scand J Gastroenterol 2011; 46: 271-276
309 Pilic D, Höfs C, Weitmann S et al. Inter- and intraobserver agreement in 24-hour combined multiple intraluminal impedance and pH measurement in children. J Pediatr Gastroenterol Nutr 2011; 53: 255-259
310 Shay S, Tutuian R, Sifrim D et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99: 1037-1043
311 Shay S, Tutuian R, Vela M. Twenty-four hour ambulatory multichannel intraluminal impedance and pH: A multicenter report of normal values from 45 healthy volunteers. Gastroenterology 2002; 122
312 Emerenziani S, Ribolsi M, Sifrim D et al. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Neurogastroenterol Motil 2009; 21: 253-258
313 Iwakiri K, Kawami N, Sano H et al. Acid and non-acid reflux in Japanese patients with non-erosive reflux disease with persistent reflux symptoms, despite taking a double-dose of proton pump inhibitor: a study using combined pH-impedance monitoring. J Gastroenterol 2009; 44: 708-712
314 Savarino E, Tutuian R, Zentilin P et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Am J Gastroenterol 2010; 105: 1053-1061
315 Savarino E, Marabotto E, Zentilin P et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis 2011; 43: 542-547
316 Weigt J, Mönkemüller K, Kolfenbach S et al. Standards und Innovationen in der Diagnostik der gastroö̧sophagealen Refluxkrankheit. Z Gastroenterol 2007; 45: 1141-1149
317 Vaezi M, Richter J. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996; 111: 1192-1199
318 Stein H, Barlow A, DeMeester T et al. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992; 216: 35-43
319 Marshall R, Anggianash A, Owen W. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997; 40: 182-187
320 Vaezi M, Singh S, Richter J. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995; 108: 1897-1907
321 Girelli C, Cuvello P, Limido E et al. Duodenogastric reflux: an update. Am J Gastroenterol 1996; 91: 648-653
322 Koek G, Tack J, Sifrim D et al. The role of acid and duodenal gastroesophageal reflux in symptomatic GERD. Am J Gastroenterol 2001; 96: 2033-2040
323 Xu X, Li Z, Zou D et al. Role of duodenogastroesophageal reflux in the pathogenesis of esophageal mucosal injury and gastroesophageal reflux symptoms. Can J Gastroenterol 2006; 20: 91-94
324 Gutschow C, Bollschweiler E, Schröder W et al. Effect of “white diet” during bile monitoring with Bilitec 2000 on esophageal pH-metry in patients with gastroesophageal reflux disease. J Gastrointest Surg 2005; 9: 508-513
325 Vaezi M, Richter J. Contribution of acid and duodenogastro-oesophageal reflux to oe- sophageal mucosal injury and symptoms in partial gastrectomy patients. Gut 1997; 41: 297-302
326 Yuasa N, Abe T, Sasaki E et al. Comparison of gastroesophageal reflux in 100 patients with or without prior gastroesophageal surgery. J Gastroenterol 2009; 44: 650-658 . Epub 2009 May 12
327 Baldini F, Bechi P, Cianchi F et al. Analysis of the optical properties of bile. J Biomed Opt 2000; 5: 321-329
328 Vaezi M, Richter J. Duodenogastroesophageal reflux and methods to monitor nonacidic reflux. Am J Med 2001; 111 (Suppl. 08) 160S-168S
329 Kauer W, Burdiles P, Ireland A et al. Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fi- beroptic sensor for bilirubin. Am J Surg 1995; 169: 98-103
330 Caldwell M, Lawlor P, Byrne P et al. Ambulatory oesophageal bile reflux monitoring in Barrett’s oesophagus. Br J Surg 1995; 82: 657-660
331 Bechi P, Pucciani F, Baldini F et al. Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique. Dig Dis Sci 1993; 38: 1297-1306
332 Barrett M, Myers J, Watson D et al. Detection of bile reflux: in vivo validation of the Bilitec fibreoptic system. Dis Esophagus 2000; 13: 44-50
333 Felix V, Viebig R. Recommended diet for reflux spectrophotometry. Article in Portuguese. Arq Gastroenterol 2003; 40: 20-24 . Epub 2003 Oct 6
334 Barrett M, Myers J, Watson I et al. Dietary interference with the use of Bilitec to assess bile reflux. Dis Esophagus 1999; 12: 60-64
335 Tack J, Bisschops R, Koek G et al. Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux. Dig Dis Sci 2003; 48: 1213-1220
336 Cuomo R, Koek G, Sifrim D et al. Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci 2000; 45: 2463-2469
337 Menges M, Müller M, Zeitz M. Increased acid and bile reflux in Barrett’s esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001; 96: 331-337